Search results
4 Small Stocks to Bet on in an Upbeat Drugs Industry
Zacks via Yahoo News· 2 years agoIt is expected that innovation will continue to drive growth in the Medical-Drugs industry in 2022. KDNY, ASRT, VIRX, SLNO may prove to be good additions...
Chinook (KDNY) Stock Rallies 24.2% in 3 Months: Here's Why
Zacks via Yahoo News· 2 years agoDespite no marketable drugs in its portfolio, Chinook (KDNY) is progressing well with its pipeline....
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance Canada· 2 months agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance Canada· 1 month agoWith the end of the first-quarter earnings season, the focus has now shifted to pipeline and...
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 2 months agoTravere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript May 6, 2024 Travere...
Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why
Zacks via Yahoo Finance Canada· 5 months agoTravere (TVTX) is on track to file an sNDA to the FDA to convert the accelerated approval for lead...
VERA Dips Despite Positive Data From IgA Nephropathy Study
Zacks via Yahoo Finance Canada· 1 year agoVera Therapeutics, Inc. VERA announced positive top-line data from the phase IIb ORIGIN study...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 3 months agoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript March 18, 2024 Alpine...
Biotech Stock Roundup: KDNY Up on NVS Buyout, BIIB & Eisai's AD Drug Update & More
Zacks via Yahoo Finance Canada· 1 year agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from bigwigs like...
Arcutis (ARQT) Up on Top-Line Data From Atopic Dermatitis Study
Zacks via Yahoo Finance Canada· 2 years agoArcutis Biotherapeutics (ARQT) reports positive top-line data from a phase III study of its lead...